BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucci C, Cosentino N, Genovese S, Campodonico J, Milazzo V, De Metrio M, Rondinelli M, Riggio D, Biondi ML, Rubino M, Celentano K, Bonomi A, Capra N, Veglia F, Agostoni P, Bartorelli AL, Marenzi G. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus. Cardiovasc Diabetol 2020;19:183. [PMID: 33081810 DOI: 10.1186/s12933-020-01157-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Genestreti PRR, Furtado RHM, Salsoso R, Dalçóquio TF, Franci A, Menezes FR, Caporrino C, Ferrari AG, Nakashima CAK, Scanavini Filho MA, Lima FG, Giraldez RRCV, Baracioli LM, Nicolau JC. Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction. JCM 2022;11:5776. [DOI: 10.3390/jcm11195776] [Reference Citation Analysis]
2 Cosentino N, Lucci C, Marenzi G. Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor? Int J Cardiol 2022:S0167-5273(22)00865-8. [PMID: 35680057 DOI: 10.1016/j.ijcard.2022.06.008] [Reference Citation Analysis]
3 Pivato CA, Jones D, Cao D, Sartori S, Chiarito M, Nicolas J, Zhang Z, Beerkens F, Nardin M, Qiu H, Razuk V, Feldman D, Kumaraguru V, Stefanini GG, Sweeny J, Baber U, Dangas G, Sharma SK, Kini A, Mehran R. Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing PCI. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.02.002] [Reference Citation Analysis]
4 Lin XL, Sun HX, Li FQ, Zhao JY, Zhao DH, Liu JH, Fan Q. Admission high‐sensitivity C‐reactive protein levels improve the Grace risk score prediction on in‐hospital outcomes in acute myocardial infarction patients. Clinical Cardiology. [DOI: 10.1002/clc.23749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sharif S, Van der Graaf Y, Cramer MJ, Kapelle LJ, de Borst GJ, Visseren FLJ, Westerink J; SMART study group. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes. Cardiovasc Diabetol 2021;20:220. [PMID: 34753497 DOI: 10.1186/s12933-021-01409-0] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
6 Witkowski M, Wu Y, Hazen SL, Tang WHW. Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes. Cardiovasc Diabetol 2021;20:171. [PMID: 34419046 DOI: 10.1186/s12933-021-01365-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Opincariu D, Rodean I, Rat N, Hodas R, Benedek I, Benedek T. Systemic Vulnerability, as Expressed by I-CAM and MMP-9 at Presentation, Predicts One Year Outcomes in Patients with Acute Myocardial Infarction-Insights from the VIP Clinical Study. J Clin Med 2021;10:3435. [PMID: 34362217 DOI: 10.3390/jcm10153435] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Oltean PB, Kovács I, Hodas R, Benedek T. Cardiovascular Risk Factors from Another Point of View. Journal of Interdisciplinary Medicine 2021;6:27-31. [DOI: 10.2478/jim-2021-0003] [Reference Citation Analysis]